Recent Finacing
Recent Raise
GrowLab Pharmaceuticals researches, develops and manufactures DNA-specific phytocannabinoid-derived therapies under EMA cGMP, conducting clinical trials across multiple indications and building biopharmaceutical campuses with high-volume commercial production.
Recent Investors
Total Raised
Funding round
Investor